MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
242.96
+8.20
+3.49%
Opening 15:32 11/09 EST
OPEN
236.00
PREV CLOSE
234.76
HIGH
244.37
LOW
235.14
VOLUME
501.96K
TURNOVER
--
52 WEEK HIGH
266.38
52 WEEK LOW
128.80
MARKET CAP
15.60B
P/E (TTM)
79.06
1D
5D
1M
3M
1Y
5Y
1D
Don't Overlook Jazz (JAZZ) International Revenue Trends While Assessing the Stock
NASDAQ · 8h ago
What Jazz Pharmaceuticals Holders Bought Into
Simply Wall St · 8h ago
Weekly Report: what happened at JAZZ last week (1102-1106)?
Weekly Report · 11h ago
Is Jazz Pharmaceuticals (JAZZ) Undervalued On Raised 2026 Guidance And Ziihera Data?
Simply Wall St · 4d ago
Jazz Advances Early JZP269 Study as Investors Await Safety Data
TipRanks · 5d ago
Jazz Pharmaceuticals (JAZZ) Stock Jumps After Q3 Results Despite EPS Loss
Simply Wall St · 5d ago
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
PR Newswire · 6d ago
Jazz Pharmaceuticals (JAZZ) Sets Revenue Record As Pipeline News Reshapes The Story
Simply Wall St · 6d ago
More
About JAZZ
Jazz Pharmaceuticals plc is a global biopharmaceutical company. It is engaged in developing medicines for people with serious diseases, often with limited or no therapeutic options. It has a diverse portfolio of marketed medicines, including therapies for sleep disorders and epilepsy, and a portfolio of cancer treatments. Its lead-marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Ziihera (zanidatamab-hrii), and Enrylaze (recombinant crisantaspase). Its product candidates include Zanidatamab, Vyxeos, JZP815, JZP898, JZP441, ABS-1230, and others. Xywav is used for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy. The Company, through Chimerix, Inc., also owns a clinical asset, dordaviprone, a novel small molecule treatment in development for H3 K27M-mutant diffuse glioma.

Webull offers Jazz Pharmaceuticals PLC stock information, including NASDAQ: JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.